Adel Rafeh El Boueiz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 19 | 2024 | 3247 | 2.050 |
Why?
|
Pulmonary Emphysema | 6 | 2024 | 683 | 1.420 |
Why?
|
Emphysema | 2 | 2024 | 234 | 0.710 |
Why?
|
Disease Progression | 13 | 2022 | 13614 | 0.680 |
Why?
|
Bronchitis, Chronic | 2 | 2021 | 81 | 0.640 |
Why?
|
Spirometry | 5 | 2021 | 928 | 0.520 |
Why?
|
Forced Expiratory Volume | 6 | 2021 | 1827 | 0.520 |
Why?
|
Bronchodilator Agents | 2 | 2019 | 514 | 0.440 |
Why?
|
Vital Capacity | 3 | 2021 | 994 | 0.410 |
Why?
|
Smoking | 6 | 2021 | 9077 | 0.410 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2010 | 693 | 0.380 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 168 | 0.360 |
Why?
|
Polyadenylation | 1 | 2021 | 114 | 0.350 |
Why?
|
Bronchitis | 1 | 2021 | 193 | 0.350 |
Why?
|
Heterozygote | 3 | 2022 | 2795 | 0.320 |
Why?
|
Xanthine Dehydrogenase | 2 | 2008 | 18 | 0.310 |
Why?
|
Professional Practice | 1 | 2010 | 313 | 0.310 |
Why?
|
Genetic Variation | 4 | 2021 | 6607 | 0.310 |
Why?
|
Activin Receptors, Type I | 1 | 2019 | 133 | 0.310 |
Why?
|
Muscular Atrophy | 1 | 2021 | 335 | 0.290 |
Why?
|
Capillary Permeability | 4 | 2009 | 767 | 0.290 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.280 |
Why?
|
Lung | 6 | 2020 | 10031 | 0.280 |
Why?
|
Respiratory Function Tests | 5 | 2022 | 1692 | 0.270 |
Why?
|
Hospitalists | 1 | 2010 | 297 | 0.270 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 553 | 0.240 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2019 | 637 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 18061 | 0.240 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 345 | 0.230 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1061 | 0.230 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1514 | 0.230 |
Why?
|
Physician's Role | 1 | 2010 | 927 | 0.220 |
Why?
|
Eosinophils | 1 | 2018 | 945 | 0.210 |
Why?
|
Asthma | 5 | 2021 | 6269 | 0.210 |
Why?
|
Phenotype | 6 | 2022 | 16706 | 0.210 |
Why?
|
Vascular Diseases | 1 | 2021 | 1159 | 0.210 |
Why?
|
Genome, Human | 2 | 2021 | 4446 | 0.210 |
Why?
|
Pulmonary Artery | 1 | 2021 | 1935 | 0.200 |
Why?
|
Genome | 1 | 2020 | 1752 | 0.200 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1349 | 0.180 |
Why?
|
Population Surveillance | 1 | 2021 | 2589 | 0.170 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15883 | 0.170 |
Why?
|
Academic Medical Centers | 1 | 2010 | 2779 | 0.170 |
Why?
|
Scleroderma, Systemic | 2 | 2010 | 345 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 7 | 2022 | 20667 | 0.170 |
Why?
|
Lung Diseases | 3 | 2008 | 1940 | 0.160 |
Why?
|
Aged | 21 | 2022 | 171050 | 0.160 |
Why?
|
Middle Aged | 25 | 2022 | 222903 | 0.160 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 325 | 0.160 |
Why?
|
Stress, Mechanical | 3 | 2010 | 1669 | 0.160 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1240 | 0.160 |
Why?
|
Herpes Genitalis | 1 | 2010 | 148 | 0.160 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2009 | 92 | 0.160 |
Why?
|
Reactive Nitrogen Species | 1 | 2008 | 35 | 0.160 |
Why?
|
Genotype | 2 | 2022 | 13024 | 0.160 |
Why?
|
Models, Theoretical | 1 | 2020 | 3563 | 0.150 |
Why?
|
Pleura | 1 | 2009 | 240 | 0.150 |
Why?
|
Genome-Wide Association Study | 5 | 2020 | 12800 | 0.140 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 437 | 0.140 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 472 | 0.140 |
Why?
|
Toxocara canis | 1 | 2007 | 1 | 0.140 |
Why?
|
Hyperuricemia | 1 | 2010 | 221 | 0.140 |
Why?
|
Toxocariasis | 1 | 2007 | 13 | 0.140 |
Why?
|
Bronchi | 1 | 2021 | 843 | 0.140 |
Why?
|
Models, Statistical | 1 | 2021 | 5088 | 0.140 |
Why?
|
Chondrosarcoma | 1 | 2009 | 301 | 0.140 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1880 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 707 | 0.130 |
Why?
|
Protein Isoforms | 2 | 2021 | 1718 | 0.130 |
Why?
|
Herpes Simplex | 1 | 2010 | 471 | 0.130 |
Why?
|
Male | 27 | 2022 | 363585 | 0.130 |
Why?
|
Apolipoprotein E4 | 1 | 2010 | 707 | 0.130 |
Why?
|
Respiration, Artificial | 3 | 2009 | 2709 | 0.120 |
Why?
|
Pulmonary Alveoli | 1 | 2008 | 664 | 0.120 |
Why?
|
Hypertension, Pulmonary | 2 | 2024 | 1603 | 0.120 |
Why?
|
Female | 25 | 2022 | 395961 | 0.120 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 790 | 0.120 |
Why?
|
Humans | 38 | 2024 | 765734 | 0.120 |
Why?
|
Herpesvirus 1, Human | 1 | 2010 | 743 | 0.120 |
Why?
|
Antioxidants | 1 | 2012 | 1670 | 0.110 |
Why?
|
Lung Injury | 1 | 2009 | 430 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2022 | 14745 | 0.110 |
Why?
|
Risk Assessment | 2 | 2022 | 24279 | 0.100 |
Why?
|
Vitamin D | 2 | 2020 | 3272 | 0.100 |
Why?
|
Quality of Life | 2 | 2021 | 13462 | 0.100 |
Why?
|
Prospective Studies | 6 | 2022 | 54795 | 0.100 |
Why?
|
Actins | 1 | 2009 | 2056 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2454 | 0.090 |
Why?
|
Aortic Diseases | 1 | 2007 | 729 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2022 | 59459 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 2008 | 2141 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 2878 | 0.090 |
Why?
|
Cluster Analysis | 2 | 2022 | 2720 | 0.090 |
Why?
|
Lung Volume Measurements | 1 | 2021 | 381 | 0.090 |
Why?
|
Adiposity | 1 | 2010 | 1891 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2010 | 2643 | 0.080 |
Why?
|
Skin Diseases | 1 | 2008 | 1080 | 0.080 |
Why?
|
Drug Utilization Review | 1 | 2010 | 248 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.080 |
Why?
|
Proteomics | 2 | 2024 | 3910 | 0.080 |
Why?
|
Extravascular Lung Water | 1 | 2009 | 21 | 0.080 |
Why?
|
Cohort Studies | 5 | 2021 | 41631 | 0.080 |
Why?
|
Mucus | 1 | 2021 | 346 | 0.080 |
Why?
|
Linear Models | 2 | 2020 | 5876 | 0.080 |
Why?
|
Protein C | 1 | 2009 | 134 | 0.080 |
Why?
|
Tomography | 1 | 2021 | 443 | 0.080 |
Why?
|
Cardiomyopathies | 1 | 2010 | 2067 | 0.070 |
Why?
|
Molecular Sequence Annotation | 1 | 2020 | 523 | 0.070 |
Why?
|
Survival Analysis | 2 | 2022 | 10069 | 0.070 |
Why?
|
Jurkat Cells | 1 | 2019 | 737 | 0.070 |
Why?
|
Quantitative Trait Loci | 2 | 2021 | 2137 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3593 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9522 | 0.070 |
Why?
|
Logistic Models | 3 | 2019 | 13261 | 0.070 |
Why?
|
Risk Factors | 6 | 2022 | 74831 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2020 | 12056 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2010 | 3969 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2010 | 3989 | 0.060 |
Why?
|
Exons | 1 | 2021 | 2391 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2495 | 0.060 |
Why?
|
Genetic Markers | 1 | 2022 | 2601 | 0.060 |
Why?
|
Dementia | 1 | 2010 | 2745 | 0.060 |
Why?
|
Acute Lung Injury | 1 | 2009 | 376 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5924 | 0.060 |
Why?
|
Genetics, Population | 1 | 2020 | 943 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15390 | 0.060 |
Why?
|
Adult | 10 | 2022 | 222974 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2018 | 1602 | 0.060 |
Why?
|
ROC Curve | 1 | 2021 | 3618 | 0.050 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1425 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 16041 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1154 | 0.050 |
Why?
|
Thrombosis | 1 | 2007 | 2949 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 29899 | 0.050 |
Why?
|
Depression | 1 | 2012 | 8230 | 0.050 |
Why?
|
Apoptosis | 1 | 2008 | 9511 | 0.050 |
Why?
|
Rodentia | 1 | 2024 | 261 | 0.050 |
Why?
|
Pedigree | 1 | 2020 | 4524 | 0.050 |
Why?
|
United States | 6 | 2021 | 72898 | 0.050 |
Why?
|
Comorbidity | 2 | 2017 | 10567 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39180 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2010 | 6203 | 0.050 |
Why?
|
Glycoproteins | 1 | 2009 | 2194 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4106 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 13079 | 0.050 |
Why?
|
Poisson Distribution | 1 | 2012 | 508 | 0.050 |
Why?
|
Methyltransferases | 1 | 2024 | 373 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1811 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2020 | 2393 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Models, Genetic | 1 | 2020 | 3447 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 268 | 0.040 |
Why?
|
Signal Transduction | 2 | 2010 | 23589 | 0.040 |
Why?
|
Odds Ratio | 1 | 2022 | 9647 | 0.040 |
Why?
|
Computational Biology | 1 | 2021 | 3558 | 0.040 |
Why?
|
Carotenoids | 1 | 2012 | 619 | 0.040 |
Why?
|
Likelihood Functions | 1 | 2012 | 993 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 992 | 0.040 |
Why?
|
Caspase 7 | 1 | 2008 | 51 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2010 | 3717 | 0.040 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 833 | 0.040 |
Why?
|
Pleural Effusion, Malignant | 1 | 2009 | 108 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 835 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1138 | 0.040 |
Why?
|
Phosphorylation | 2 | 2009 | 8279 | 0.040 |
Why?
|
Sample Size | 1 | 2021 | 843 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1724 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59852 | 0.030 |
Why?
|
Self Report | 1 | 2018 | 3772 | 0.030 |
Why?
|
Computer Simulation | 1 | 2020 | 6252 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1227 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 291 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2008 | 429 | 0.030 |
Why?
|
Animals | 8 | 2024 | 168731 | 0.030 |
Why?
|
Caspase 3 | 1 | 2008 | 731 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15648 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6307 | 0.030 |
Why?
|
Demography | 1 | 2010 | 1641 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1741 | 0.030 |
Why?
|
Mice | 5 | 2024 | 81792 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13448 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26284 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12509 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2728 | 0.030 |
Why?
|
Risk-Taking | 1 | 2010 | 1021 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2009 | 762 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1707 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2022 | 22224 | 0.030 |
Why?
|
Mental Recall | 1 | 2010 | 1217 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2010 | 14445 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11888 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2010 | 22321 | 0.030 |
Why?
|
Gene Expression | 2 | 2021 | 7584 | 0.030 |
Why?
|
Fibrosis | 1 | 2010 | 2068 | 0.030 |
Why?
|
Histones | 1 | 2024 | 2592 | 0.030 |
Why?
|
Prevalence | 2 | 2010 | 15833 | 0.030 |
Why?
|
Gene Frequency | 1 | 2010 | 3623 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6893 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17062 | 0.020 |
Why?
|
Transcription Factors | 1 | 2022 | 12123 | 0.020 |
Why?
|
Sex Factors | 1 | 2016 | 10605 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2740 | 0.020 |
Why?
|
Leukocytes | 1 | 2008 | 2027 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 6018 | 0.020 |
Why?
|
Health Surveys | 1 | 2010 | 4057 | 0.020 |
Why?
|
Child | 2 | 2018 | 80499 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6499 | 0.020 |
Why?
|
Radiography | 1 | 2009 | 6917 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23704 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2008 | 3140 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2009 | 291 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7123 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2009 | 755 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2009 | 741 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2009 | 412 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1746 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 751 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3526 | 0.020 |
Why?
|
Blood Glucose | 1 | 2010 | 6427 | 0.020 |
Why?
|
Mutation | 1 | 2020 | 30184 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2019 | 65180 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9441 | 0.010 |
Why?
|
Diet | 1 | 2010 | 8085 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21478 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 88781 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3794 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81457 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2817 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18289 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 40066 | 0.010 |
Why?
|